The eyes of 100-day-old Beagles were exposed to 35 MeV protons at surface doses of 70, 125, 240, and 480 rad. Dose-dependent responses in the adnexa were observed 5 days after irradiation and in the crystalline lens, with a slitlamp biomicroscope, beginning at 30 days and appearing most marked 50-130 days post exposure. A grading system was established to quantitate the degree of lens involvement. An apparent "threshold" dose for vision-impairing lens opacifications occurring within 6 months of exposure was found to be between 70-125 rad surface dose. Large vacuoles and plaques, aberrant lens fiber cells, and subcapsular epithelial hyperplasia and metaplasia were the most profound histologic changes, occurring in the crystalline lenses of eyes receiving surface doses of 240 and 480 rad. Similar but less severe lens pathology was seen at a surface dose of 125 rad. Eyes receiving 480 rad also had corneal keratinization and vascularization, iridic atrophy, depigmentation, and entropion uveae. Detailed clinical and histopathologic observations are reported.
Skip Nav Destination
Close
Article navigation
1 February 1973
Research Article|
February 01 1973
Proton Irradiation of Beagle Eyes: II. Clinical and Histopathologic Observations for 35 MeV Protons
Radiat Res (1973) 53 (2): 255–266.
Citation
Peggy L. Horn, Moshe Shifrine; Proton Irradiation of Beagle Eyes: II. Clinical and Histopathologic Observations for 35 MeV Protons. Radiat Res 1 February 1973; 53 (2): 255–266. doi: https://doi.org/10.2307/3573531
Download citation file:
Close
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your InstitutionCiting articles via
Commonalities Between COVID-19 and Radiation Injury
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Pataje G. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia C. Formenti, Chandan Guha, Dale J. Hu, Mohammad K. Khan, David G. Kirsch, Sunil Krishnan, Wolfgang W. Leitner, Brian Marples, William McBride, Minesh P. Mehta, Shahin Rafii, Elad Sharon, Julie M. Sullivan, Ralph R. Weichselbaum, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Kathryn D. Held
Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light
Manuela Buonanno, Brian Ponnaiya, David Welch, Milda Stanislauskas, Gerhard Randers-Pehrson, Lubomir Smilenov, Franklin D. Lowy, David M. Owens, David J. Brenner